GPBAR1 and obesity disorder: was recently reported to potentiate obesity-related colorectal cancer progression in a mouse model (42); this effect was attributed in part to enhanced TGR5 signaling as a result of increased levels of deconjugated DCA and lithocholic acid in the colon.